Accuray (ARAY) Non-Current Deffered Revenue (2011 - 2026)

Accuray's (ARAY) quarterly Non-Current Deffered Revenue came in at $27.0 million in Q1 2026, up 5.5% year-on-year from $25.6 million in Q1 2025, and down 2.22% quarter-over-quarter from $27.6 million in Q4 2025.

Accuray (ARAY) Non-Current Deffered Revenue (2011 - 2026) Analysis & Trends

Accuray's Non-Current Deffered Revenue history runs 16 years deep, the most recent figure standing at $27.0 million for Q1 2026.

  • On a quarterly basis, Non-Current Deffered Revenue rose 5.5% year-over-year to $27.0 million in Q1 2026; TTM through Mar 2026 was $27.0 million, a 5.5% increase from a year earlier, with the FY2025 full-year figure at $26.6 million, up 10.17% from the prior year.
  • Non-Current Deffered Revenue fell to $27.0 million in Q1 2026 per ARAY's latest filing, from $27.6 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $30.4 million in Q4 2022 and bottomed at $23.6 million in Q1 2024.
  • The 5-year median for Non-Current Deffered Revenue is $25.8 million (2025), against an average of $26.2 million.
  • Across the five-year window, Non-Current Deffered Revenue grew 20.58% in 2022 and declined 19.22% in 2024, its largest moves.
  • Year by year, Non-Current Deffered Revenue stood at $30.4 million in 2022, then declined by 18.28% to $24.8 million in 2023, then declined by 0.78% to $24.6 million in 2024, then increased by 12.16% to $27.6 million in 2025, then fell by 2.22% to $27.0 million in 2026.
  • Per Business Quant, the three latest ARAY Non-Current Deffered Revenue figures stand at $27.0 million (Q1 2026), $27.6 million (Q4 2025), and $25.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 512.79 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Accuray 29,832.96 -38.50 Mn 25.29 Mn 27.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 27.00 Mn
Dec 31, 2025 27.61 Mn
Sep 30, 2025 25.82 Mn
Jun 30, 2025 26.57 Mn
Mar 31, 2025 25.59 Mn
Dec 31, 2024 24.62 Mn
Sep 30, 2024 24.47 Mn
Jun 30, 2024 24.11 Mn
Mar 31, 2024 23.62 Mn
Dec 31, 2023 24.81 Mn
Sep 30, 2023 26.94 Mn
Jun 30, 2023 27.08 Mn
Mar 31, 2023 29.25 Mn
Dec 31, 2022 30.36 Mn
Sep 30, 2022 28.45 Mn
Jun 30, 2022 24.69 Mn
Mar 31, 2022 24.55 Mn
Dec 31, 2021 25.18 Mn
Sep 30, 2021 23.83 Mn
Jun 30, 2021 23.69 Mn